{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:50:21Z","timestamp":1790733021727,"version":"4.1.0"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.critrevonc.2022.103753","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T11:49:55Z","timestamp":1657021795000},"page":"103753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia"],"prefix":"10.1016","volume":"177","author":[{"given":"Rahul","family":"Bhattacharjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmita","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojaswi","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandragauda R.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanakya Nath","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2022.103753_bib1","series-title":"Innovative Medicine","first-page":"307","article-title":"TIM-3 is a novel therapeutic target for eradicating acute myelogenous leukemia stem cells","author":"Akashi","year":"2015"},{"key":"10.1016\/j.critrevonc.2022.103753_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.06.001","article-title":"Mechanisms and consequences of constitutive activation of integrin-linked kinase in acute myeloid leukemia","volume":"43","author":"Alasseiri","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/ol.2011.455","article-title":"Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process","volume":"3","author":"Albeniz","year":"2012","journal-title":"Oncol. Lett."},{"issue":"18","key":"10.1016\/j.critrevonc.2022.103753_bib4","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1101\/gad.1111603","article-title":"Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9","volume":"17","author":"Ayton","year":"2003","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib5","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41467-020-19722-9","article-title":"Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes","volume":"11","author":"Barbour","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2022.103753_bib6","first-page":"2019","article-title":"Targeting leukemia stem cell-niche dynamics: a new challenge in AML treatment","author":"Bernasconi","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103753_bib7","first-page":"2018","article-title":"Role of HOX genes in stem cell differentiation and cancer","author":"Bhatlekar","year":"2018","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.critrevonc.2022.103753_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103675","article-title":"Mechanistic Role of HPV-Associated Early Proteins in Cervical Cancer: Molecular Pathways and Targeted Therapeutic Strategies","author":"Bhattacharjee","year":"2022","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1158\/1078-0432.CCR-19-2479","article-title":"EGFL7 antagonizes NOTCH signaling and represents a novel therapeutic target in acute myeloid leukemia","volume":"26","author":"Bill","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.leu.2403145","article-title":"Constitutive NF-\u03ba B DNA-binding activity in AML is frequently mediated by a Ras\/PI3-K\/PKB-dependent pathway","volume":"18","author":"Birkenkamp","year":"2004","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103753_bib11","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1182\/blood.V92.11.4325","article-title":"Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)\/CD71(-)\/HLA-DR","volume":"92","author":"Blair","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103753_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/leu.2011.95","article-title":"The role of Smad signaling in hematopoiesis and translational hematology","volume":"25","author":"Blank","year":"2011","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.critrevonc.2022.103753_bib13","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1182\/blood-2014-12-618090","article-title":"TGF-\u03b2 signaling in the control of hematopoietic stem cells","volume":"125","author":"Blank","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103753_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/fon.13.195","article-title":"Hox gene dysregulation in acute myeloid leukemia","volume":"10","author":"Braekeleer","year":"2014","journal-title":"Future Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1083\/jcb.200112059","article-title":"14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport","volume":"156","author":"Brunet","year":"2002","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib18","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1038\/ncomms7471","article-title":"Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia","volume":"6","author":"Buchner","year":"2015","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/cancers12061518","article-title":"DUBs activating the hedgehog signaling pathway: a promising therapeutic target in cancer","volume":"12","author":"Bufalieri","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.trecan.2017.03.004","article-title":"Selective targeting of RSK isoforms in cancer","volume":"3","author":"Casalvieri","year":"2017","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib21","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.leu.2405074","article-title":"The role of CALM\u2013AF10 gene fusion in acute leukemia","volume":"22","author":"Caudell","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13402-016-0297-1","article-title":"Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer","volume":"40","author":"Chavez-Gonzalez","year":"2017","journal-title":"Cell. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.leu.2404623","article-title":"Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia","volume":"21","author":"Chowdhury","year":"2007","journal-title":"Leukemia"},{"issue":"374","key":"10.1016\/j.critrevonc.2022.103753_bib24","doi-asserted-by":"crossref","first-page":"eaaj2025","DOI":"10.1126\/scitranslmed.aaj2025","article-title":"CD99 is a therapeutic target on disease stem cells in myeloid malignancies","volume":"9","author":"Chung","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib25","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers7030851","article-title":"Hedgehog signaling in the maintenance of cancer stem cells","volume":"7","author":"Cochrane","year":"2015","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/leu.2011.1","article-title":"CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia","volume":"25","author":"Coles","year":"2011","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s40425-019-0611-3","article-title":"Gal9\/Tim-3 expression level is higher in AML patients who fail chemotherapy","volume":"7","author":"Dama","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2022.103753_bib28","article-title":"Hypoxia and Hypoxia-Inducible Factors in Leukemias. Frontiers in oncology","volume":"6","author":"Deynoux","year":"2016"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00930-1","article-title":"Role of CD47 in hematological malignancies","volume":"13","author":"Eladl","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"25","key":"10.1016\/j.critrevonc.2022.103753_bib30","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1182\/blood-2010-10-315721","article-title":"p90RSK2 is essential for FLT3-ITD\u2013but dispensable for BCR-ABL\u2013induced myeloid leukemia","volume":"117","author":"Elf","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib31","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020102118","article-title":"Adaptive responses to mTOR gene targeting in hematopoietic stem cells reveal a proliferative mechanism evasive to mTOR inhibition","volume":"118","author":"Fan","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1871520614666140309225912","article-title":"Current view on the mechanism of action of perifosine in cancer","volume":"14","author":"Fensterle","year":"2014","journal-title":"Anti-Cancer Agents Med. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/cdd.2011.179","article-title":"FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression","volume":"19","author":"Ferber","year":"2012","journal-title":"Cell death Differ."},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5306\/wjco.v11.i5.260","article-title":"CITED2 and the modulation of the hypoxic response in cancer","volume":"11","author":"Fernandes","year":"2020","journal-title":"World J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103753_bib35","doi-asserted-by":"crossref","first-page":"8121","DOI":"10.1074\/jbc.M114.548651","article-title":"3-Deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation","volume":"289","author":"Fujiwara","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103753_bib36","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/cas.13019","article-title":"Small\u2010molecule Hedgehog inhibitor attenuates the leukemia\u2010initiation potential of acute myeloid leukemia cells","volume":"107","author":"Fukushima","year":"2016","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib37","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.stem.2009.03.015","article-title":"Hedgehog signaling is dispensable for adult hematopoietic stem cell function","volume":"4","author":"Gao","year":"2009","journal-title":"Cell stem Cell"},{"issue":"1454","key":"10.1016\/j.critrevonc.2022.103753_bib38","article-title":"Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia","volume":"11","author":"van Gils","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2022.103753_bib39","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","article-title":"The tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells","volume":"22","author":"Gon\u00e7alves Silva","year":"2017","journal-title":"EBioMedicine"},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103753_bib40","first-page":"1209","article-title":"Antibodies TC-12 (\u201cunique\u201d) and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia","volume":"26","author":"Gramatzki","year":"1998","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib41","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.leu.2403653","article-title":"PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways","volume":"19","author":"Grandage","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2022.103753_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-7342-8_1","article-title":"Signaling pathways in leukemic stem cells","volume":"1143","author":"Gurska","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib43","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/stem.1597","article-title":"Concise review: leukemia stem cells in personalized medicine","volume":"32","author":"Guzman","year":"2014","journal-title":"Stem Cells"},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103753_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125832","article-title":"PI3K alpha and delta promote hematopoietic stem cell activation","volume":"4","author":"Hemmati","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12885-020-06760-1","article-title":"CD45dimCD34+CD38\u2212CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia","volume":"20","author":"Heo","year":"2020","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103753_bib46","doi-asserted-by":"crossref","first-page":"8526","DOI":"10.1002\/jcp.26792","article-title":"EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis","volume":"233","author":"Hong","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"26","key":"10.1016\/j.critrevonc.2022.103753_bib47","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2022.103753_bib48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/OTT.S103790","article-title":"FLT3 inhibitors: clinical potential in acute myeloid leukemia","volume":"10","author":"Hospital","year":"2017","journal-title":"OncoTargets Ther."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/leu.2017.284","article-title":"RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia","volume":"32","author":"Hospital","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2022.103753_bib50","series-title":"Seminars in cancer biology","first-page":"53","article-title":"Defining the role of the RSK isoforms in cancer","author":"Houles","year":"2018"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib51","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.leu.2402363","article-title":"Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities","volume":"16","author":"Hulkkonen","year":"2002","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00204-014-1433-1","article-title":"The Hedgehog pathway: role in cell differentiation, polarity and proliferation","volume":"89","author":"Jia","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2009.04.018","article-title":"Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells","volume":"5","author":"Jin","year":"2009","journal-title":"Cell stem Cell"},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103753_bib54","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.biocel.2012.09.006","article-title":"The R-spondin family of proteins: emerging regulators of WNT signaling","volume":"44","author":"Jin","year":"2012","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103753_bib55","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41390-019-0370-3","article-title":"CD82 supports survival of childhood acute myeloid leukemia cells via activation of Wnt\/\u03b2-catenin signaling pathway","volume":"85","author":"Ji","year":"2019","journal-title":"Pediatr. Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103753_bib56","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.clml.2019.11.018","article-title":"Tracing leukemia stem cells and their influence on clinical course of adult acute myeloid","volume":"20","author":"Kandeel","year":"2020","journal-title":"Leuk. Clin. Lymphoma, Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20121527","article-title":"Notch activation inhibits AML growth and survival: a potential therapeutic approach","volume":"210","author":"Kannan","year":"2013","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1600-0609.1996.tb01330.x","article-title":"Analysis of CD34\u2013positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry","volume":"56","author":"Kanter\u2010Lewensohn","year":"1996","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103753_bib60","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.3390\/cancers11121821","article-title":"LSD1\/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target","volume":"11","author":"Karakaidos","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1097-2765(03)00358-7","article-title":"CK2 is a C-terminal I\u03baB kinase responsible for NF-\u03baB activation during the UV response","volume":"12","author":"Kato Jr","year":"2003","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103753_bib62","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.3390\/cancers12113253","article-title":"Deubiquitinating enzyme-mediated signaling networks in cancer stem cells","volume":"12","author":"Kaushal","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13941","article-title":"CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia","volume":"173","author":"Kersten","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib64","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/bjh.13941","article-title":"CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia","volume":"173","author":"Kersten","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib65","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s12185-013-1433-6","article-title":"TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells","volume":"98","author":"Kikushige","year":"2013","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib66","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.stem.2010.11.014","article-title":"TIM-3 Is a promising target to selectively kill acute myeloid leukemia stem cells","volume":"7","author":"Kikushige","year":"2010","journal-title":"Cell stem Cell"},{"key":"10.1016\/j.critrevonc.2022.103753_bib67","article-title":"Wnt\/\u00df-catenin: a new therapeutic approach to acute myeloid leukemia","author":"Kim","year":"2011","journal-title":"Leuk. Res. Treat. 2011"},{"key":"10.1016\/j.critrevonc.2022.103753_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.redox.2015.06.019","article-title":"Redox regulation of FoxO transcription factors","volume":"6","author":"Klotz","year":"2015","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib69","first-page":"160","article-title":"Simultaneous loss of \u03b2-and \u03b3-catenin does not perturb hematopoiesis or lymphopoiesis","volume":"111","author":"Koch","year":"2008","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib70","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-09-2551","article-title":"Highly phosphorylated FOXO3A is an adverse prognostic factor in acute myeloid leukemia","volume":"16","author":"Kornblau","year":"2010","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib71","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.stem.2009.11.001","article-title":"Cited2 is an essential regulator of adult hematopoietic stem cells","volume":"5","author":"Kranc","year":"2009","journal-title":"Cell stem Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib72","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s40778-017-0090-8","article-title":"Notch signaling in the regulation of hematopoietic stem cell","volume":"3","author":"Lampreia","year":"2017","journal-title":"Curr. stem Cell Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib73","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s40778-017-0090-8","article-title":"Notch signaling in the regulation of hematopoietic stem cell","volume":"3","author":"Lampreia","year":"2017","journal-title":"Curr. stem Cell Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103753_bib74","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1158\/0008-5472.CAN-14-2676","article-title":"Targeting mitochondria with avocatin B induces selective leukemia cell death","volume":"75","author":"Lee","year":"2015","journal-title":"Cancer Res."},{"issue":"6937","key":"10.1016\/j.critrevonc.2022.103753_bib75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","article-title":"Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells","volume":"423","author":"Lessard","year":"2003","journal-title":"nature"},{"issue":"(291","key":"10.1016\/j.critrevonc.2022.103753_bib76","article-title":"Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia","volume":"7","author":"Lim","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib77","article-title":"Hedgehog signaling in hematopoiesis","volume":"20","author":"Lim","year":"2010","journal-title":"Crit. ReviewsTM Eukaryot. Gene Expr."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021469","article-title":"Protein kinase CK2: structure, regulation and role in cellular decisions of life and death","volume":"369","author":"Litchfield","year":"2003","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib79","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm1512","article-title":"Chromosome 5q deletion and epigenetic suppression of the gene encoding \u03b1-catenin (CTNNA1) in myeloid cell transformation","volume":"13","author":"Liu","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-019-1179-y","article-title":"MiR-29b\/Sp1\/FUT4 axis modulates the malignancy of leukemia stem cells by regulating fucosylation via Wnt\/\u03b2-catenin pathway in acute myeloid leukemia","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib81","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chembiol.2004.11.009","article-title":"Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase","volume":"12","author":"Liu","year":"2005","journal-title":"Chem. Biol."},{"key":"10.1016\/j.critrevonc.2022.103753_bib82","series-title":"Encyclopedia of Signaling Molecules","first-page":"2862","article-title":"LGR4 (Leucine-Rich Repeat G-Protein Coupled Receptor 4)","author":"Liu","year":"2018"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-7771-1-23","article-title":"The emerging roles of Notch signaling in leukemia and stem cells","volume":"1","author":"Liu","year":"2013","journal-title":"Biomark. Res."},{"key":"10.1016\/j.critrevonc.2022.103753_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.10.013","article-title":"CD123 and its potential clinical application in leukemias","volume":"122","author":"Liu","year":"2015","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib85","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1159\/000443075","article-title":"Targeting GLI1 suppresses cell growth and enhances chemosensitivity in CD34+ enriched acute myeloid leukemia progenitor cells","volume":"38","author":"Long","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib86","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.bbrc.2018.06.139","article-title":"The peptide mimicking small extracellular loop domain of CD82 inhibits tumor cell migration, adhesion and induces apoptosis by inhibiting integrin mediated signaling","volume":"503","author":"Luan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib87","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.stem.2012.05.026","article-title":"Temporal changes in PTEN and mTORC2 regulation of hematopoietic stem cell self-renewal and leukemia suppression","volume":"11","author":"Magee","year":"2012","journal-title":"Cell stem Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib88","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.cdd.4401604","article-title":"Protein kinase CK2 phosphorylates and upregulates Akt\/PKB","volume":"12","author":"Di Maira","year":"2005","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103753_bib89","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1073\/pnas.0900089106","article-title":"Dysregulated gene expression networks in human acute myelogenous leukemia stem cells","volume":"106","author":"Majeti","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib90","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2009.05.045","article-title":"CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells","volume":"138","author":"Majeti","year":"2009","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2022.103753_bib91","first-page":"196","article-title":"The role of tumor stem-cells in regrowth of the tumor following drastic applications","volume":"15","author":"Makino","year":"1959","journal-title":"Acta - Unio Int. Contra Cancrum"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib92","doi-asserted-by":"crossref","first-page":"371","DOI":"10.18632\/oncotarget.477","article-title":"Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment","volume":"3","author":"Martelli","year":"2012","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib93","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3390\/cancers11050629","article-title":"The key roles of PTEN in T-Cell acute lymphoblastic leukemia development, progression, and therapeutic response","volume":"11","author":"Martelli","year":"2019","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103753_bib94","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.229997","article-title":"CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax","volume":"105","author":"Mattes","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.critrevonc.2022.103753_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exphem.2019.03.003","article-title":"Transcriptional regulators CITED2 and PU. 1 cooperate in maintaining hematopoietic stem cells","volume":"73","author":"Mattes","year":"2019","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-019-0726-5","article-title":"Targeting CLL-1 for acute myeloid leukemia therapy","volume":"12","author":"Ma","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/MOH.0000000000000441","article-title":"Transcription factors FOXO in the regulation of homeostatic hematopoiesis","volume":"25","author":"Menon","year":"2018","journal-title":"Curr. Opin. Hematol."},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103753_bib98","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1158\/1078-0432.CCR-08-1123","article-title":"Structural and functional alterations of FLT3 in acute myeloid leukemia","volume":"15","author":"Meshinchi","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103753_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131350","article-title":"miR-203 inhibits frizzled-2 expression via CD82\/KAI1 expression in human lung carcinoma cells","volume":"10","author":"Mine","year":"2015","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib100","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.leu.2402874","article-title":"Constitutive phosphorylation of Akt\/PKB protein in acute myeloid leukemia: its significance as a prognostic variable","volume":"17","author":"Min","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2022.103753_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fonc.2017.00019","article-title":"Inhibition of DNA and histone methylation by 5-Aza-2\u2019-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on antineoplastic action and gene expression in myeloid leukemic cells","volume":"7","author":"Momparler","year":"2017","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib102","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/jcb.26326","article-title":"Inhibition of human mesenchymal stem cell proliferation via Wnt signaling activation","volume":"119","author":"Moon","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"7281","key":"10.1016\/j.critrevonc.2022.103753_bib103","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","article-title":"TGF-\u03b2\u2013FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia","volume":"463","author":"Naka","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.8","article-title":"The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells","volume":"7","author":"Nishida","year":"2017","journal-title":"Blood Cancer J."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103753_bib105","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/cam4.482","article-title":"Blockade of CD 82 by a monoclonal antibody potentiates anti\u2010leukemia effects of AraC in vivo","volume":"4","author":"Nishioka","year":"2015","journal-title":"Cancer Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103753_bib106","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/leu.2011.127","article-title":"Notch signaling in mammalian hematopoietic stem cells","volume":"25","author":"Pajcini","year":"2011","journal-title":"Leukemia"},{"issue":"25","key":"10.1016\/j.critrevonc.2022.103753_bib107","doi-asserted-by":"crossref","first-page":"9759","DOI":"10.1074\/jbc.RA118.002743","article-title":"Differential activities and mechanisms of the four R-spondins in potentiating Wnt\/\u03b2-catenin signaling","volume":"293","author":"Park","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib108","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/leu.2011.385","article-title":"Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways","volume":"26","author":"Piazza","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2022.103753_bib109","doi-asserted-by":"crossref","unstructured":"Quere, R., Karlsson, Gr, Hertwig, F., Rissler, M., Lindqvist, B., Fioretos, T., Vandenberghe, P., Slovak, M.L., Reckzeh, K., Cammenga, Jr, 2010. SMAD4 sequestrates HOXA9 to protect hematopoietic stem cells against leukemia transformation. American Society of Hematology.","DOI":"10.1182\/blood.V116.21.3153.3153"},{"key":"10.1016\/j.critrevonc.2022.103753_bib110","doi-asserted-by":"crossref","unstructured":"Ramanathan, A., Schreiber, S.L., 2009. Direct control of mitochondrial function by mTOR. Proceedings of the National Academy of Sciences 106(52), 22229\u201322232.","DOI":"10.1073\/pnas.0912074106"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib111","first-page":"309","article-title":"Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in human acute myeloid leukemia. Blood","volume":"111","author":"Rawat","year":"2008","journal-title":"J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib112","doi-asserted-by":"crossref","first-page":"830","DOI":"10.18632\/oncotarget.971","article-title":"Pharmacologic targeting of the PI3K\/mTOR pathway controls release of angioregulators from primary human acute myeloid leukemia cells and their neighboring stromal cells","volume":"4","author":"Reikvam","year":"2013","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib113","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/bj3540605","article-title":"Roles of the forkhead in rhabdomyosarcoma (FKHR) phosphorylation sites in regulating 14-3-3 binding, transactivation and nuclear targetting","volume":"354","author":"Rena","year":"2001","journal-title":"Biochem. J."},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103753_bib114","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/sj.leu.2404754","article-title":"Aberrant marker expression patterns on the CD34+CD38\u2212 stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission","volume":"21","author":"van Rhenen","year":"2007","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.critrevonc.2022.103753_bib115","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2007-03-083048","article-title":"The novel AML stem cell\u2013associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells","volume":"110","author":"van Rhenen","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib116","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1172\/JCI31861","article-title":"HOX deregulation in acute myeloid leukemia","volume":"117","author":"Rice","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib117","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/10409238.2017.1325828","article-title":"The role of Wnt signaling in hematopoietic stem cell development","volume":"52","author":"Richter","year":"2017","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib118","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.leu.2401694","article-title":"Novel mechanisms of drug resistance in leukemia","volume":"14","author":"Ross","year":"2000","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103753_bib119","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1091\/mbc.E18-05-0305","article-title":"The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells","volume":"29","author":"Saito-Reis","year":"2018","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib120","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ccell.2020.05.014","article-title":"Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia","volume":"38","author":"Salik","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib121","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.cyto.2012.12.023","article-title":"Cytokine profiles in acute myeloid leukemia patients at diagnosis: survival is inversely correlated with IL-6 and directly correlated with IL-10 levels","volume":"61","author":"Sanchez-Correa","year":"2013","journal-title":"Cytokine"},{"issue":"10","key":"10.1016\/j.critrevonc.2022.103753_bib122","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ni1387","article-title":"Hematopoietic stem cell and multilineage defects generated by constitutive \u03b2-catenin activation","volume":"7","author":"Scheller","year":"2006","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib123","first-page":"640","article-title":"Hematopoietic stem cell: self\u2010renewal versus differentiation","volume":"2","author":"Seita","year":"2010","journal-title":"Wiley Interdiscip. Rev.: Syst. Biol. Med."},{"key":"10.1016\/j.critrevonc.2022.103753_bib124","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebiom.2017.07.018","article-title":"The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells","volume":"22","author":"Silva","year":"2017","journal-title":"EBioMedicine"},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103753_bib125","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1038\/sj.onc.1208431","article-title":"Constitutive activation of the Wnt\/\u03b2-catenin signalling pathway in acute myeloid leukaemia","volume":"24","author":"Simon","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.18632\/oncotarget.500","article-title":"A novel co-operative mechanism linking TGF\u03b2 and Lyn kinase activation to imatinib resistance in chronic myeloid leukaemia cells","volume":"3","author":"Smith","year":"2012","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib127","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.stem.2011.05.004","article-title":"Functional crosstalk between Bmi1 and MLL\/Hoxa9 axis in establishment of normal hematopoietic and leukemic stem cells","volume":"8","author":"Smith","year":"2011","journal-title":"Cell stem Cell"},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103753_bib128","doi-asserted-by":"crossref","first-page":"7628","DOI":"10.1158\/0008-5472.CAN-11-2745","article-title":"Wnt inhibitor screen reveals iron dependence of \u03b2-catenin signaling in cancers","volume":"71","author":"Song","year":"2011","journal-title":"Cancer Res."},{"issue":"29","key":"10.1016\/j.critrevonc.2022.103753_bib129","doi-asserted-by":"crossref","first-page":"45575","DOI":"10.18632\/oncotarget.10039","article-title":"Expression of functional neuronal receptor latrophilin 1 in human acute myeloid leukaemia cells","volume":"7","author":"Sumbayev","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2022.103753_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00155","article-title":"Fatty acid metabolism, bone marrow adipocytes, and AML","volume":"10","author":"Tabe","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2022.103753_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062785","article-title":"TGF-\u03b2-neutralizing antibody 1D11 enhances cytarabine-induced apoptosis in AML cells in the bone marrow microenvironment","volume":"8","author":"Tabe","year":"2013","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.critrevonc.2022.103753_bib132","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.leukres.2010.09.022","article-title":"Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells","volume":"35","author":"Takahashi","year":"2011","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib133","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/cells8040312","article-title":"Targeting hedgehog (Hh) pathway for the acute myeloid leukemia treatment","volume":"8","author":"Terao","year":"2019","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.critrevonc.2022.103753_bib134","first-page":"6259","article-title":"NOTCH signaling roles in acute myeloid leukemia cell growth and interaction with other stemness-related signals","volume":"34","author":"Tohda","year":"2014","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib135","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1074\/jbc.M009134200","article-title":"The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus: implications for PTEN stability to proteasome-mediated degradation","volume":"276","author":"Torres","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib136","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/cam4.2007","article-title":"CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells","volume":"8","author":"Touzet","year":"2019","journal-title":"Cancer Med."},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103753_bib137","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1200\/JCO.2008.18.7948","article-title":"Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group","volume":"27","author":"Tsukimoto","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib138","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/leu.2016.209","article-title":"Protein kinase CK2 regulates AKT, NF-\u03baB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia","volume":"31","author":"Tubi","year":"2017","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11693-015-9161-2","article-title":"TGF-\u03b2 signaling and its role in the regulation of hematopoietic stem cells","volume":"9","author":"Vaidya","year":"2015","journal-title":"Syst. Synth. Biol."},{"issue":"22","key":"10.1016\/j.critrevonc.2022.103753_bib140","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V128.22.1540.1540","article-title":"CD99 is highly expressed in Acute Myeloid Leukemia (AML) and presents a viable therapeutic target","volume":"128","author":"Vaikari","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.critrevonc.2022.103753_bib141","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1084\/jem.20150452","article-title":"Hif-1\u03b1 and Hif-2\u03b1 synergize to suppress AML development but are dispensable for disease maintenance","volume":"212","author":"Vukovic","year":"2015","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib142","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.stemcr.2018.05.017","article-title":"TGF-\u03b21 negatively regulates the number and function of hematopoietic stem cells","volume":"11","author":"Wang","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"5973","key":"10.1016\/j.critrevonc.2022.103753_bib143","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/\u03b2-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.critrevonc.2022.103753_bib144","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41388-020-1201-z","article-title":"Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1\u03b1 with echinomycin","volume":"39","author":"Wang","year":"2020","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell stem Cell"},{"issue":"42","key":"10.1016\/j.critrevonc.2022.103753_bib146","doi-asserted-by":"crossref","first-page":"32592","DOI":"10.1074\/jbc.M001358200","article-title":"Tumor necrosis factor \u03b1-induced phosphorylation of RelA\/p65 on Ser529 is controlled by casein kinase II","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2022.103753_bib147","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3390\/cancers11121827","article-title":"FLT3-ITD activates RSK1 to enhance proliferation and survival of AML cells by activating mTORC1 and eIF4B cooperatively with PIM or PI3K and by inhibiting bad and BIM","volume":"11","author":"Watanabe","year":"2019","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib148","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2002-11-3429","article-title":"Survival of acute myeloid leukemia cells requires PI3 kinase activation","volume":"102","author":"Xu","year":"2003","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.critrevonc.2022.103753_bib149","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1038\/emboj.2010.292","article-title":"ROS-mediated amplification of AKT\/mTOR signalling pathway leads to myeloproliferative syndrome in Foxo3(-\/-) mice","volume":"29","author":"Yalcin","year":"2010","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103753_bib150","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/ncb1460","article-title":"Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1","volume":"8","author":"Yao","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"7092","key":"10.1016\/j.critrevonc.2022.103753_bib151","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells","volume":"441","author":"Yilmaz","year":"2006","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.critrevonc.2022.103753_bib152","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2011.85","article-title":"Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells","volume":"25","author":"Yuan","year":"2011","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.critrevonc.2022.103753_bib153","first-page":"211","article-title":"Acute myeloid leukemia: advancements in diagnosis and treatment","volume":"130","author":"Yu","year":"2017","journal-title":"Chin. Med J. (Engl. )"},{"issue":"18","key":"10.1016\/j.critrevonc.2022.103753_bib154","first-page":"5928","article-title":"CD82\/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-\u03b21","volume":"22","author":"Zeng","year":"2018","journal-title":"Eur. Rev. Med Pharm. Sci."},{"issue":"7092","key":"10.1016\/j.critrevonc.2022.103753_bib155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention","volume":"441","author":"Zhang","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib156","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2016.151555","article-title":"CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2\/p27kip1 signaling","volume":"102","author":"Zhang","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.critrevonc.2022.103753_bib157","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3324\/haematol.2016.151555","article-title":"CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2\/p27(kip1) signaling","volume":"102","author":"Zhang","year":"2017","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.critrevonc.2022.103753_bib158","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41419-020-02946-4","article-title":"HOTAIR contributes to the carcinogenesis of gastric cancer via modulating cellular and exosomal miRNAs level","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"15","key":"10.1016\/j.critrevonc.2022.103753_bib159","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.1203210109","article-title":"Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1","volume":"109","author":"Zhang","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2022.103753_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/sj.leu.2403220","article-title":"Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias","author":"Zhao","year":"2004","journal-title":"Leukemia (08876924) 18(2)"},{"issue":"1","key":"10.1016\/j.critrevonc.2022.103753_bib161","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood-2010-01-266320","article-title":"A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway","volume":"118","author":"Zheng","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2022.103753_bib162","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822001779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842822001779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:43:07Z","timestamp":1760902987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842822001779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":162,"alternative-id":["S1040842822001779"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103753","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103753","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103753"}}